Earendil Labs
Business Services · Delaware, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Middletown, Delaware, 19709, United Stat...Website
earendil.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
3
1
1
About Earendil Labs
Earendil.bio is a biotechnology and artificial intelligence company focused on advancing protein-based therapeutics by combining computational modeling with biological research, using machine learning to accelerate drug discovery and improve therapeutic design; from a third-party perspective, it is seen as part of a broader shift toward integrating AI with life sciences to enhance research efficiency and enable more precise, scalable approaches to modern biopharmaceutical development.Explore more
Popular SearchesEarendil LabsSIC Code 87,873NAICS Code 54,541Show moreEarendil Labs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Earendil Labs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Earendil Labs
Website visits: Recent activity has been detected on your website
Check out if Earendil Labs is spiking on competitors!
Funding: Get notified immidiatlly once Earendil Labs has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Earendil Labs has recently received funding, and reach out quickly before it becomes old news!
Earendil Labs, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Earendil Labs launches new products
Click to see if Earendil Labs had a recent Job posting/layoffs
Earning: See what the market has to say on Earendil Labs recently announced quarterly report
Recommended Actions
Find VP level buyers at Earendil Labs
Find more new buyers
Company Profile Activity
Activity Insights
Earendil Labs is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Earendil Labs is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Earendil Labs.
Earendil Labs financials insights
Gather financial insights about Earendil Labs, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Unspecified
$787M
Earendil Labs News & Media
Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis
WILMINGTON, Del., April 2, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has been dosed in a Phase IIa clinical trial of HXN-1001, a half-life extended anti-TL1A antibody, in patients with ulcerative colitis, as well as enrollment completion in the Phase I trial of the antibody in healthy volunteers carried out in Australia. The Phase IIa trial is a randomized, placebo-controlled study to evaluate theEarendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development
WILMINGTON, Del., March 20, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced that it has raised $787 million in financing rounds. The investment included participation by a group of leading global investors, including Dimension Capital, DST Global, INCE Capital, Luminous Ventures, Miracle Capital, Sanofi, and Biotech Development Fund (created by Hillhouse and Pfizer), alongside other existing and new technology and healthEarendil Labs and WuXi Biologics Enter Strategic Collaboration to Accelerate Development and Manufacturing of Bispecific/Multispecific Antibodies and ADCs
WILMINGTON, Del., March 12, 2026 /PRNewswire/ -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), today...WuXi XDC Enters Strategic Collaboration with Earendil Labs on WuXiTecan-2 Payload-Linker Technology Platform
SHANGHAI, Feb. 27, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, today announced a strategic...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Earendil Labs
Sign Up For FreeTo access detailed company insights
Earendil.bio is a biotechnology and artificial intelligence company focused on advancing protein-based therapeutics by combining computational modeling with biological research, using machine learning to accelerate drug discovery and improve therapeutic design; from a third-party perspective, it is seen as part of a broader shift toward integrating... Read More
